HTFL
$26.02
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide.
Recent News
Heartflow (HTFL) Soars 27% as Firm Guns For Double-Digit Growth
Heartflow Inc. (NASDAQ:HTFL) is one of the 10 Stocks Gaining Momentum Fast. Heartflow jumped by 26.99 percent week-on-week, as investors took heart from its double-digit revenue growth outlook for the year, supported by a strong performance in 2025. In an updated report earlier in the week, the company said that it grew its revenues by […]
Is HeartFlow Stock a Buy After Capricorn Investment Group Bought 1.7 Million Shares?
HeartFlow delivers AI-powered, non-invasive cardiac diagnostics to healthcare providers seeking advanced imaging and decision support tools.
HeartFlow Inc (HTFL) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...
HeartFlow Inc (HTFL) reports a 40% revenue increase and unveils new AI-driven tools, setting the stage for continued expansion and competitive advantage.
Heartflow Q4 Earnings Call Highlights
Heartflow (NASDAQ:HTFL) executives highlighted record revenue, accelerating adoption of its platform, and expanding reimbursement support during the company’s fourth-quarter 2025 earnings call, while also initiating 2026 guidance and outlining product and clinical milestones expected over the next y
HeartFlow: Q4 Earnings Snapshot
The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share. The medical technology company posted revenue of $49.1 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $46.6 million.